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1. Introduction  
Medicinal plants are the nature’s gift to 
human being to cure disease and make disease 
free life. Herbal medicine is still the backbone 
of about 75-80% of the total population (Ali 
MS et al., 2018). Plant’s secondary metabolites 
are important sources for scientific and clinical 
study as well as for new drug development. 
Many plant synthesized herbal medicines in 
different formulations used for treatment of 
various diseases from an ancient time. 
Traditional or indigenous drugs have special 
importance. Phytochemicals as secondary 
metabolites and they can be used in the 
pharmaceutical industries for producing a 
potent drug (Nag M et al., 2018). Terpenes are 
volatile organic compounds which are the 
major odoriferous constituents of essential oil 
and contain two or more 5-carbon isoprene 
units. Many terpenes contain additional 
functioning groups, such as carboxyl (COOH), 
carbonyl (CO), alkoxy (OR) and hydroxyl 
(OH). It is tested over a long time, and is 
relatively safe, easily available and affordable 
(Kupchan, Meshulam, & Sneden, 1978). Many 
ethno-botanical survey reported that, the local 
population in different parts of the world 
including the USA, China, India, Mexico, 
Morocco, Saudi Arabia, Taiwan, and Trinidad 
and Tobago depend on medicinal plant and 
suggested that several medicinal plants have 
been used as dietary adjuncts for the cure of 
numerous chronic and severe disease (H 
Stuppner & Moller, 1993). In India and China, 
the use of herbal medicines has been 
commonly used from a long time, as a less 
expensive way to treat various health 
problems. The herbal drugs are less toxic with 
limited side effects compared with synthetic 
drugs (DINAN et al., 1997). Due to such 
reasons, traditional and complementary 
medicines have seen an increase in their 
popularity for the treatment of different 
diseases. The WHO has also recommended the 
initiation of studies to identify and characterize 
new herbal preparations from traditionally 
known plants and the development of new 
effective therapeutic agents, especially in the 
areas where the lack of safe modern drugs to 
treat chronic diseases. Cancer is a chronic 
disease and serious health threats for about 
seven million people in a year and a big 
challenge medical science (Makar, Saha, & 
Singh, 2018). In the ongoing search for more 
effective and safer drugs, attention is being 
paid to new and safe medicinal herbs or food 
components. Although phyto-therapy 
continues to be used in several countries as in 
the past, only a few plants have received 
scientific or medical scrutiny (Kaushik, Aeri, 
& Mir, 2015). Although most of the herbal 
plants are safer, still a number of medicinal 
plants possess some degree of toxicity; 
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therefore it is very important to analyze the 
traditional therapeutic regimens scientifically 
and their dosing, toxicity and other health 
consequences, before proper use in human 
diseased conditions. Now a days the 
environment becomes highly polluted with 
variety of toxic chemical and waste biological 
active substances such as dyes, polymers, 
steroids, phytochromes, or the ubiquitous free 
radicals (Dinan, Harmatha, & Lafont, 2001). 
Cucurbitacin are terpenoids category of diverse 
compounds found in the plants of family 
Cucurbitaceae. These compounds have 
medicinal and toxic properties. These 
compounds are also discovered in other plant 
families like Scrophulariaceae, Cruciferae, 
Datiscaceae, Primulaceae, Rubiaceae etc. The 
diversity of Cucurbitacin lies in variety of its 
side chain derivatives that contribute to their 
disparate pharmacological actions. The bitter 
taste of plant species like cucumber has been 
identified to the presence of Cucurbitacin. The 
first Cucurbitacin was isolated as a crystalline 
form substance in 1831 and was named α-
elaterin (Gamlath, Gunatilaka, Alvi, & 
Balasubramaniam, 1988). 
 
Figure. 1 (a) Isoprene unit and (b) triterpene (Squalene) 
2. Occurrence 
Cucurbitacins are found in many 
cucurbitaceous plants. They are most common 
in species of the Bryonia, Cucumis, Cucurbita, 
Luffa, Echinocystis, Lagenaria and Citrullus. 
The plants of genera Momordica contain a 
special group of Cucurbitacins called 
momordicosides. The level of Cucurbitacins 
varies between tissues. They may be 
concentrated in fruits and roots of mature 
plants. In fruits where Cucurbitacins are 
produced, their highest concentration is 
achieved on maturity. Seeds generally contain 
very low concentration of Cucurbitacins.  
 
 
Figure.2 General structure of Cucurbitacin (Gry, 2006) 
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Cucurbitacin producing plants have also 
been identified outside the cucurbitaceae in the 
members of Scrophulariaceae, Begoniaceae, 
Primulaceae, Liliaceae, Tropaeolaceae and 
Rosaceae. The seeds of certain cruciferous 
plants, like Iberis species and Lepidium 
sativum also contain cucurbitacins. It is 
reported that Cucurbitacins are formed in situ 
and are not transported to another parts of the 
plant. The distribution of Cucurbitacins among 
several families of plant kingdom (Hermann 
Stuppner, Müller, & Wagner, 1991). 
3. Chemistry of Cucurbitacins 
Cucurbitacins are a group of highly 
oxygenated triterpenoid molecules found in 
diverse species of cucurbitaceae family 
(Zheng, Fu, & Pei, 2007). They are derived 
from the cucurbitane scaffold. That are widely 
present intraditional Chinese medicines, 
possess strong anticancer activity, andare 
divided into 12 classes from A to T with over 
200 derivatives. All cucurbitacins contain a 
basic 19-(10→9β)–abeo--10α–lanost–5--ene 
ring skeleton. A common feature among all 
compounds in the category of Cucurbitacins is 
the presence of 5, (6)-double bond. The 
difference of Cucurbitacins from steroidal 
moiety lies in the fact that in basic structure of 
Cucurbitacins a methyl group is located at C-9 
rather than C-10. Most of the Cucurbitacins are 
tetracyclic, but some representatives have an 
additional ring due to formal cyclization 
between C-16 and C-24 as in cucurbitacins S 
and T. The Cucurbitacins differ from most of 
the other tetracyclic triterpenes by being highly 
unsaturated and contains numerous keto, 
hydroxyl, and acetoxy groups. Certain 
Cucurbitacins have been discovered in the 
form of glycosides and some of them lack C-
11 carbonyl function. Chemically, 
Cucurbitacins are ranked according to presence 
of various functional groups on rings A and C, 
diversity in side chain and stereo chemical 
considerations. The structural composition of 
following Cucurbitacins are known and have 
been designated by the letters: A, B, C, D, E, 
F, G, H, I, J, K, L, O, P, Q, R and S. The term -
“Cucurbitacin” refers to group of 
Cucurbitacins along with their glyosidic forms 
mentioned above. Cucurbitacin G and H have 
same structures but differ from each other in 
the configuration of the hydroxyl group at 
position 24 which is not yet established. 
Cucurbitacin R was   demonstrated to be 23, 
24-dihydrocucurbitacin D (DHCD) hence, its 
description has been moved to the group of 
Cucurbitacin D. Similarly Cucurbitacin J and 
K differ from each other only in the 
configuration of hydroxyl group at position 24 
which is yet to be determined. A special group 
of Cucurbitacins are called as momordicosides, 
named after their occurrence in Momordica 
charantia. Momordicosides have never been 
identified in any other plant species. The 
common feature of momordicosides is that 
C19 has been oxidized to an aldehyde group. 
The saccharide linkage is generally present 
at C-2 (2-O-β-glycosides) in Cucurbitacin 
glycosides. Majority of Cucurbitacins are 
usually crystalline in nature or present in the 
form of needles at room temperature except 
Cucurbitacin H which is an amorphous solid. 
Most Cucurbitacins are soluble in petroleum 
ether, chloroform, benzene, ethyl acetate, 
methanol and ethanol, but are insoluble in 
ether. They are only slightly soluble in water. 
Cucurbitacins usually have absorption maxima 
for ultraviolet light wavelength (λ) between 
228-234 nm (J. C. Chen, Chiu, Nie, Cordell, & 
Qiu, 2005). Nine cucumber genes are also 
responsible for biosynthesis of cucurbitacins 
and elucidated four catalytic steps. 
The transcription factors Bl (Bitter leaf) and 
Bt (Bitter fruit) that control this pathway in 
leaves and fruits, respectively. The Bi gene 
confers bitterness to the entire plant and is 
genetically related with an operon-like gene 
cluster, similar to the gene cluster involved in 
thalianol biosynthesis in Arabidopsis. Fruit 
bitterness requires both Bi and the dominant Bt 
(Bitter fruit) gene. Non bitterness of cultivated 
cucumber fruit is conferred by bt, an allele 
selected during domestication. Bi is a member 
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Table. 1 Structures of Cucurbitacins 
 
 
4. Anticancer activity of Cucurbitacin and 
its derivatives 
Cancer is a rapidly growing health threat. 
Cancer is a group of diseases in which the 
abnormal growth of cells with the potential 
spread to other parts of the body. Not all 
tumors are cancerous in the starting phase and 
do not spread to other parts of the body. The 
sign and symptoms include a lump, abnormal 
bleeding, prolonged cough, unexplained 
weight loss etc. these symptoms may indicate 
cancer (Kaushik et al., 2015). The cancer is a 
serious diseases cause 8.8 million people 
worldwide died from cancer in 2015. That is 
nearly 1 in 6 of all global deaths. Only 5-10% 
of all cancer cases can be attributed to genetic 
defects, whereas the remaining 90-95% has 
their roots in the environment and life style. 
The life style factors include cigarette 
smoking, diet, alcohol, sun exposure, 
environmental pollutants, infections, stress, 
obesity, and physical in activity (Teuscher, 
1994). The evidence indicates that of all cancer 
related deaths, almost 25-30% are due to 
tobacco, as many as 30-35% are linked to diet, 
about 15-20% are due to infections, and the 
remaining percentage are due to other factors 
like radiation, stress, physical activity, 
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environmental pollutants (Enslin, Joubert, & 
Rehm, 1956). It presents the biggest challenge 
to researchers and medical professionals and 
has been selected for various prevention and 
therapeutic strategies. The dietary intake of 
many vegetables and fruits has been found to 
reduce the risk of occurrence of cancer. Cancer 
is the deregulation of apoptosis that 
programmed cell death. Several promising 
targets for intervention is identified by 
studying the molecular abnormalities that 
tumor genesis, such as the signal transduction 
pathways that regulate apoptosis. In this 
perspective, cucurbitacins and its derivatives 
have become a new focus for cancer treatment 
because of their strong capability to inhibit 
several cancer. The target area of cucurbitacins 
and its derivatives through JAK/STAT 
pathway, Wnt signaling and MAPK pathway 
(Njoroge & Newton, 1994). Cucurbitacin and 
its derivatives are inhibited cancer growth via a 
wide range of mechanisms, including 
proapoptosis, induction of autophagy, cell 
cycle arrest, inhibition of cancer invasion, and 
migration. Cucurbitacins also modulate 
multiple intracellular signaling pathways. 
It is interesting that each variant of 
cucurbitacins may trigger slightly different 
molecular signaling cascades in different 
cancer cell types to inhibit cancer growth and 
progress (Lavie, Willner, & Merenlender, 
1964). Signal transducers and activators of 
transcription 3 (STAT3) and Janus kinase 
(JAK) signaling pathways are the main 
mechanisms for cucurbitacins to induce 
apoptosis to exert their potent anticancer 
effect. In addition, the ability of cucurbitacins 
to induce cell cycle arrest in G2/M phase 
mediated by various regulators is also an 
important way to fight against various cancers 
(Bartalis & Halaweish, 2005). 
 
 
Figure. 3 (a) Mechanism of STAT signaling pathway leading to activation (Bowman, Yu, Sebti, 
Dalton, & Jove, 1999) (b) Canonical and noncanonical Wnt signaling pathway 
Cancer is responsible for 12% of the 
world’s mortality. Treatments include surgery, 
and radio- and/or chemo-therapy. However, 
chemotherapy suffers limitations of side-
effects, toxicity and drug resistance. Also, 
most established chemotherapy drugs are 
lacking specificity toward tumor cells.(1) 
Therefore, there has been a growing interest in 
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the use of herbs as a promising source of more 
efficient new therapeutic anticancer drugs. In 
addition, recent trends in the management of 
cancer development include increasing 
awareness and chemoprevention that suggest 
using natural or synthetic chemicals to prevent 
initiation and promotional events associated 
with cancer development. Marine and 
terrestrial plants and animals are the main 
sources of natural products. They are 
considered as a fertile ground for finding novel 
antitumor drugs. Medicinal plants, used in folk 
medicine worldwide, are studied in ethno-
botany and ethno-pharmacology. Up to the 
present date, more than 40 new cucurbitacins 
and cucurbitacin-derived compounds have 
been isolated from the cucurbitaceae family 
and from other species of the plant Kingdome. 
The most significant mechanisms with regard 
to the apoptotic effects of cucurbitacins are 
their ability to modify mitochondrial trans-
membrane potential and transcriptional 
activities via nuclear factors or genes and their 
capability to activate or inhibit pro- or anti-
apoptotic proteins. In general, cucurbitacins 
are considered to be selective inhibitors of the 
JAK/STAT pathways; however, other 
mechanisms may be implicated in their 
apoptotic effects, including the MAPK 
pathway (known to be important for cancer 
cell proliferation and survival), PARP 
cleavage, expression of active caspase-3, 
decreased pSTAT3 and JAK3 levels, as well as 
decreases in various downstream STAT3 
targets such as Mcl-1, Bcl-2, Bcl-xL, and 
cyclin D3, all of which are implicated in 
apoptosis and the cell cycle control 
5. Physical properties and solubility of 
Cucurbitacins 
At room temperature, cucurbitacins are 
generally crystalline substances. The chemical 
structure of cucurbitacins reveals their 
possession of hydrophobic properties, and thus 
poor water solubility. (1) To date, only a 
limited number of polymeric micellar systems 
have shown positive results in tumor targeted 
delivery of poorly soluble drugs after systemic 
administration. (2) Polyethylene oxide block 
micelles are nanoscopic carriers (20 – 100 nm 
in size) with a hydrophilic shell/hydrophobic 
core structure that have shown great promise in 
the solubility and controlled delivery of 
hydrophobic drugs. (3) Poly (ethylene oxide)-
block-poly (ε-caprolactone) (PEO-b-PCL) and 
poly (ethylene oxide)-block-poly (α-benzyl 
carboxylate ε-caprolactone) (PEO-b-PBCL) 
micelles (<90 nm) were engineered by a co-
solvent evaporation technique as nanocarriers 
for the delivery of cucurbitacins, which are 
inhibitors of the signal transducer and activator 
of transcription 3 (STAT3). It was determined 
that the anti-cancer and STAT3 inhibitory 
activity of the polymeric micellar cucurbitacins 
were comparable to the free drugs on a B16-
F10 melanoma cell line in vitro. Intra-tumoral 
injection of 1 mg/kg/day cucurbitacin I 
resulted in the regression of established B16-
F10 mouse melanoma tumors in vivo. In 
comparison to free cucurbitacin I , PEO-b-
PBCL micellar cucurbitacin I was found to 
provide comparable anti-cancer effects against 
B16-F10 tumors and limit drug levels in 
animal serum while maintaining high drug 
levels in tumor following intra-tumoral 
administration. The results indicate the 
potential of polymeric micelles as suitable 
vehicles for the delivery of cucurbitacins I and 
B. Interestingly, the toxicity associated with 
cucurbitacins I and B was significantly 
reduced when these drugs were loaded into the 
nanoparticles. 
Cucurbitacins, Stats and Tumerorigenesis 
Signal transducers and activators of 
transcription (STATs) are a family of seven 
proteins including STAT 1, 2, 3, 4, 5a, 5b, and 
6. STAT3 protein is ubiquitously expressed in 
most tissues. (4) Each has its unique function 
to transduce extracellular signals and directly 
modulate transcription. STAT proteins play 
important role in regulation of immune 
response, inflammation, proliferation, 
differentiation, development, cell survival, and 
apoptosis. (5) STATs are initially present in 
inactive forms in the cytoplasm. Upon 
stimulation by a wide variety of receptor-
mediated growth factors such as platelet-
derived growth factor (PDGF) or epidermal 
growth factor (EGF) (6) and cytokines such as 
interleukin-6 (IL-6) or interferon (7) signaling, 
STATs associate the cell membrane receptors 
to be activated via phosphorylation at 
conserved tyrosine 705 residues either directly 
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by receptor tyrosine kinases, or indirectly by 
non-receptor tyrosine kinases, e.g., Janus 
kinases (JAKs) and Src oncogenic kinase. The 
JAKs then phosphorylation of tyrosine 705 
induces STAT dimerization, nuclear 
translocation, and DNA binding at STAT-
specific sequence in the promoter regions of 
their target genes to stimulate their 
transcription. (8) Additionally, serine at the 
727
th
 residue in the same domain must also be 
phosphorylated for complete transcriptional 
activity. (9) In normal physiological 
conditions, the activation duration of STAT 
protein especially STAT3 is temporary and 
strictly controlled illustrates the JAK/STAT 
pathway for activation and inhibition. 
6. Conclusion 
Cucurbitacin structures are characterized by 
the tetracyclic cucurbitane nucleus 
(triterpenes) with a variety of oxygen 
substitutions at different positions. Because of 
the possession of hydrophobic properties and 
poorly soluble water, polymeric micellar 
systems exhibited improved antitumor efficacy 
because of a better solubilization and targeting 
after local and / or systemic administration. 
Different cucurbitacin compounds exhibit 
antitumor proliferation inhibition and induce 
apoptosis alone or synergistically with other 
proven anticancer chemicals and cytokines - 
using numerous human cancer cell lines and 
tumor xenografts of leukemia, lymphoma, 
breast, prostate, lung, uterine cervix, liver, 
skin, colon, laryngeal, brain and pancreatic 
cancers. In a structure-function related manner, 
cucurbitacins’ inhibition of phosphorylation of 
STAT3 and/or JAK2 and their subsequent 
activation seamed as the major mechanism of 
their action. 
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